Abstract
Series of N-, S- and Br-derivatives of betulinic, oleanolic, and ursolic acids have been synthesized and screened for their in vitro antitumor activity (cytotoxicity). N-Methylpiperazinylamide of 2-[3-pyridinylidene]-ursolic acid and methyl 2-methylideneureido-betulonate have shown significant cytotoxic activity against the PC3 cancer cells (IC50 = 8 μM) and HCT-116 cell line (IC50 = 5.7 μM).
Similar content being viewed by others
REFERENCES
Chudzik, M., Korzonek-Szlacheta, I., and Król, W., Molecules, 2015, vol. 20, pp. 1610–1625.
Hussain, H., Green, I.R., Shamraiz, U., Saleem, M., Badshah, A., Abbas, G., Rehman, N.U., and Irs, M., Expert. Opin. Ther. Pat., 2018, vol. 28, no. 5, pp. 383–398.
Eroshenko, D.V., Krainova, G.F., Konysheva, A.V., Dmitriev, M.V., and Grishko, V.V., Bioorg. Med. Chem. Lett., 2018, vol. 28, nos. 23–24, pp. 3752–3760.
Kahnt, M.H., Al-Harrasi, L.F.N., and Csuk, R., Molecules, 2018, vol. 23, no. 10, p. 2558.
Pokorny, J., Krajcovicova, S., Hajduch, M., Holoubek, M., Gurska, S., Dzubak, P., Volna, T., Popa, I., and Urban, M., Future Med. Chem., 2018, vol. 10, no. 5, pp. 483–491.
Khusnutdinova, E.F., Petrova, A.V., Apryshko, G.N., Kukovinets, O.S., and Kazakova, O.B., Russ. J. Bioorg. Chem., 2018, vol. 44, no. 3, pp. 322−329.
Khusnutdinova, E.F., Petrova, A.V., Kukovinets, O.S., and Kazakova, O.B., Nat. Prod. Comm., 2018, vol. 13, no. 6, pp. 665−668.
Giniyatyllina, G.V., Smirnova, I.E., Kazakova, O.B., Yavorskaya, N.P., Golubeva, I.S., Zhukova, O.S., Pugacheva, R.B., Apryshko, G.N., and Poroikov, V.V., Med. Chem. Res., 2015, vol. 24, pp. 3423–3436.
Kazakova, O.B., Smirnova, I.E., Khusnutdinova, E.F., Zhukova, O.S., Fetisova, L.V., Apryshko, G.N., Medvedeva, N.I., Yamansarov, E.Y., Baikova, I.P., Nguyen, T.T., and Thu, H.D.T., Russ. J. Bioorg. Chem., 2014, vol. 40, no. 5, pp. 558–567.
Khusnutdinova, E.F., Apryshko, G.N., Petrova, A.V., Kukovinets, O.S., and Kazakova, O.B., Russ. J. Bioorg. Chem., 2018, vol. 1, no. 1, pp. 123–127.
Khusnutdinova, E.F., Lopatina, T.V., Kazakova, O.B., Akhmatshina, G.F., and Kukovinets, O.S., Chem. Nat. Comp., 2014, vol. 50, no. 5, pp. 853–856.
Zhou, M., Zhang, R.-H., Wang, M., Xu, G.-B., and Liao, S.-G., Eur. J. Med. Chem., 2017, vol. 131, pp. 222–236.
Gupta, N., Rath, S.K., Singh, J., Qayum, A., Singh, S., and Sangwan, P.L., Eur. J. Med. Chem., 2017, vol. 135, pp. 517–530.
Mosmann, T., J. Immunol. Methods, 1983, vol. 65, no. 1, pp. 55–63.
Mironov, A.N., Metodicheskie rekomendatsii po doklinicheskomu izucheniyu protivoopukholevoi aktivnosti lekarstvennykh sredstv. Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv (Guidelines for Preclinical Study of the Antitumor Activity of Drugs. Guidance for Conducting Preclinical Studies of Drugs), Moscow: Grif i K, 2012, part 1, pp. 642–656.
Filimonov, D.A. and Poroikov, V.V., Ross. Khim. Zh., 2006, vol. 50, pp. 66–75.
Filimonov, D.A. and Poroikov, V.V., in Chemoinformatics Approaches to Virtual Screening, Varnek, A. and Tropsha, A., Eds., RSC Publishing, 2008, pp. 182–216.
Filimonov, D.A., Lagunin, A.A., Gloriozova, T.A., Rudik, A.V., Druzhilovskii, D.S., Pogodin, P.V., and Poroikov, V.V., Khim. Geterotsikl. Soedin., 2014, vol. 3, pp. 483–499.
Kazakova, O.B., Giniyatullina, G.V., Tolstikov, G.A., Medvedeva, N.I., Utkina, T.M., and Kartashova, O.L., Russ. J. Bioorg. Chem., 2010, vol. 36, no. 3, pp. 383–389.
Flekhter, O.B., Boreko, E.I., Nigmatullina, L.R., Pavlova, N.I., Medvedeva, N.I., Nikolaeva, S.N., Ashavina, O.A., Savinova, O.V., Baltina, L.A., Galin, F.Z., and Tolstikov, G.A., Pharm. Chem. J., 2004, vol. 38, no. 7, pp. 10–13.
Flekhter, O.B., Boreko, E.I., Pavlova, N.I., Nikolaeva, S.N., Savinova, O.V., Eremin, V.F., Baltina, L.A., Galin, F.Z., and Tolstikov, G.A., Russ. J. Bioorg. Chem., 2003, vol. 29, no. 3, pp. 296–302.
Flekhter, O.B., Karachurina, L.T., Poroikov, V.V., Nigmatullina, L.P., Baltina, L.A., Zarudii, F.S., Davydova, D.A., Spirikhin, L.V., Baikova, I.P., Galin, F.Z., and Tolstikov, G.A., Russ. J. Bioorg. Chem., 2000, vol. 26, no. 3, pp. 192–200.
Boreko, E.I., Pavlova, N.I., Savinova, O.V., Nikolaeva, S.N., Flekhter, O.B., Phyzhova, N.S., and Nikandrov, V.N., NewsBiomed. Sci, 2002, no. 3, pp. 86–91.
Flekhter, O.B., Giniyatullina, G.V., Galin, F.Z., Baschenko, N.Zh., Makara, N.S., Zarudii, F.S., Boreko, E.I., Savinova, O.V., Pavlova, N.I., Starikova, Z.A., and Tolstikov, G.A., Chem. Nat. Comp., 2005, vol. 41, no. 6, pp. 706–709.
Funding
The synthesis of compounds (I), (II), and (IV)‒(XIII) was performed according to the State Task no. AAAA-A17-117011910023-2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any studies with the use of animals or humans as research subjects.
Conflict of Interest
The authors state that there are no conflict of interests.
Additional information
Translated by A. Levina
Corresponding author: fax: +7 (347) 235-60-66; e-mail: ElmaH@inbox.ru.
Rights and permissions
About this article
Cite this article
Khusnutdinova, E.F., Petrova, A.V., Kazakova, O.B. et al. Synthesis and Cytotoxicity of Triterpenic Acids Modified at C3 and C28 Positions. Russ J Bioorg Chem 45, 552–557 (2019). https://doi.org/10.1134/S1068162019050042
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162019050042